167 related articles for article (PubMed ID: 20094970)
1. Somatostatin receptor subtype expression in human thyroid tumours.
Klagge A; Krause K; Schierle K; Steinert F; Dralle H; Fuhrer D
Horm Metab Res; 2010 Apr; 42(4):237-40. PubMed ID: 20094970
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
Ain KB; Taylor KD; Tofiq S; Venkataraman G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
[TBL] [Abstract][Full Text] [Related]
3. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptors and disease: role of receptor subtypes.
Hofland LJ; Lamberts SW
Baillieres Clin Endocrinol Metab; 1996 Jan; 10(1):163-76. PubMed ID: 8734455
[TBL] [Abstract][Full Text] [Related]
5. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
7. Evidence for Somatostatin receptor 2 in thyroid tissue.
Druckenthaner M; Schwarzer C; Ensinger C; Gabriel M; Prommegger R; Riccabona G; Decristoforo C
Regul Pept; 2007 Jan; 138(1):32-9. PubMed ID: 16996150
[TBL] [Abstract][Full Text] [Related]
8. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours.
Jaïs P; Terris B; Ruszniewski P; LeRomancer M; Reyl-Desmars F; Vissuzaine C; Cadiot G; Mignon M; Lewin MJ
Eur J Clin Invest; 1997 Aug; 27(8):639-44. PubMed ID: 9279525
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
Reubi JC; Schaer JC; Waser B; Mengod G
Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
[TBL] [Abstract][Full Text] [Related]
12. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.
Corbetta S; Ballaré E; Mantovani G; Lania A; Losa M; Di Blasio AM; Spada A
Eur J Clin Invest; 2001 Mar; 31(3):208-14. PubMed ID: 11264647
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor expression in thyroid disease.
Atkinson H; England JA; Rafferty A; Jesudason V; Bedford K; Karsai L; Atkin SL
Int J Exp Pathol; 2013 Jun; 94(3):226-9. PubMed ID: 23672766
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Xie YM; Yan LN; Wei B; Guo MM; Tang CW
Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.
de Sá SV; Corrêa-Giannella ML; Machado MC; de Souza JJ; Pereira MA; Patzina RA; Siqueira SA; Machado MC; Giannella-Neto D
Endocr Relat Cancer; 2006 Mar; 13(1):69-78. PubMed ID: 16601280
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.
Bruno JF; Xu Y; Berelowitz M
Biochem Biophys Res Commun; 1994 Aug; 202(3):1738-43. PubMed ID: 7914724
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.
Taboada GF; Luque RM; Bastos W; Guimarães RF; Marcondes JB; Chimelli LM; Fontes R; Mata PJ; Filho PN; Carvalho DP; Kineman RD; Gadelha MR
Eur J Endocrinol; 2007 Jan; 156(1):65-74. PubMed ID: 17218727
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours.
Fuhrer D; Eszlinger M; Karger S; Krause K; Engelhardt C; Hasenclever D; Dralle H; Paschke R
Eur J Endocrinol; 2005 May; 152(5):785-90. PubMed ID: 15879365
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas.
Bläker M; Schmitz M; Gocht A; Burghardt S; Schulz M; Bröring DC; Pace A; Greten H; De Weerth A
J Hepatol; 2004 Jul; 41(1):112-8. PubMed ID: 15246216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
